Canada Med Stop

Provider Profile Name: Canada Med Stop
Type: Telehealth Provider
Website: canadamedstop.com
Phone: 1-877-202-1513
Service Area: Florida
Consultation Type: Virtual

Operating Details

• Virtual consultations — no in-person visits
• Monday–Friday 5:00 AM–10:00 PM PST
• Saturday–Sunday: Closed
• Pharmacist counselling available
• No medical director listed publicly

Approach Canada Med Stop is an international pharmacy referral service that helps U.S. customers access prescription medications from licensed international pharmacies at reduced prices. The company acts as an intermediary, leveraging government price controls in other countries to make medications more affordable for American patients.

About the Company

Canada Med Stop operates as an international pharmacy referral service connecting U.S. patients — primarily those in Florida — with licensed international pharmacies. Rather than functioning as a traditional telehealth clinic, the service focuses on the prescription fulfillment side of the GLP-1 access equation: helping patients who already have a prescription obtain their medications at significantly lower out-of-pocket cost than U.S. retail pricing allows.

The service was established after Canada Drug Stop closed in late 2018, stepping in to help Americans access Canadian pharmacy pricing for medications they were already prescribed. Canada Med Stop is recognized as a Canadian medical referral service that uses licensed pharmacies to fulfill orders, with its primary purpose being to provide affordable medication to Americans who find local prices prohibitive.

All medications dispensed through Canada Med Stop are processed by its affiliated Canadian pharmacy, which is duly licensed in the province of British Columbia by the College of Pharmacists of British Columbia. The service holds CIPA (Canadian International Pharmacy Association) and IPABC (International Pharmacy Association of British Columbia) certifications — meaningful trust signals in a cross-border pharmacy space where unverified international sites pose real risks to patients.

GLP-1 Weight Loss

• Lose pounds of fat every week
• Money Back Guarantee
• No membership or hidden fees! Everything you need is included
• Start for just $179, no insurance required + free shipping

GLP-1 for Just $179

100k MembersHSA/FSA ApprovedFrom $179

No medical director is publicly listed for Canada Med Stop, which is consistent with its referral service model — prescribing decisions remain with the patient’s own licensed provider, not with Canada Med Stop staff.

GLP-1 Offerings and Weight Loss Services

Canada Med Stop’s GLP-1 offerings are limited in scope compared to full-service telehealth weight loss platforms. The service does not conduct clinical evaluations, prescribe GLP-1 medications, or operate a structured weight loss program. Its role is restricted to medication access and fulfillment for patients who already hold a valid prescription.

GLP-1 Medications:

• Compounded Semaglutide — availability not confirmed at time of publication; patients should contact Canada Med Stop directly to verify current stock and fulfillment capability

The service does not list tirzepatide, Wegovy, Zepbound, or other GLP-1 options in its confirmed medication offerings at this time.

What Canada Med Stop does not provide:

• Telehealth consultations or prescribing
• GLP-1 eligibility assessments or medical evaluations
• Weight loss coaching or lifestyle curriculum
• Prior authorization assistance
• Outcome tracking or follow-up care

Patients considering Canada Med Stop for GLP-1 access should already have an established relationship with a prescribing provider. The service fills an affordability gap — not a clinical one.

Pricing by Type and What Reviewers Say

No pricing data is publicly listed for Canada Med Stop’s GLP-1 offerings at the time of this review. The service does not publish a medication price list on its homepage — patients are directed to search by medication name or contact the customer care team for a quote.

What is well established is the general cost context that drives patients to Canadian pharmacy referral services. A month’s supply of Ozempic in Canada typically costs between $200–$300 CAD, compared to the U.S. list price of over $1,000 per month. Wegovy in Canada costs approximately $400–$529 CAD per month without insurance — significantly lower than U.S. retail pricing. Whether Canada Med Stop’s specific pricing for compounded semaglutide falls in line with, above, or below these Canadian market benchmarks cannot be confirmed without a direct quote from the service.

The company advertises savings of up to 90% compared to U.S. prices, with no co-pays, deductibles, tiers, or insurance requirements — just the Canadian drug price.

Important legal note for U.S. patients: Importing prescription medications from Canada for personal use sits in a regulatory grey area under U.S. federal law. The FDA technically prohibits personal importation but has historically exercised enforcement discretion for personal-use quantities of medications already prescribed by a licensed provider. Patients should consult their physician and understand applicable regulations before proceeding.

Reviews from Trustpilot and Google

No approved reviews are currently listed for Canada Med Stop on the BariatricReports.org platform, and no large-volume independent review pool was identified on Trustpilot or Google at the time of writing. The service does not appear to have accumulated the kind of third-party patient feedback trail that established GLP-1 telehealth platforms carry.

On-site testimonials on the Canada Med Stop website speak to the ordering and customer service experience rather than clinical outcomes — which is expected given the service’s fulfillment-focused model. Reviewers cite helpful customer service associates, smooth renewal processes, and professional interactions.

Without independent verified reviews covering GLP-1-specific experiences — including compounded semaglutide availability, shipping reliability, and medication quality — prospective patients cannot fully assess the service through third-party channels at this time.

Compounding Pharmacies Used

Canada Med Stop’s compounding pharmacy partners are not publicly identified. The service lists compounded semaglutide as an offering pending confirmation, but does not name the compounding facilities it works with, disclose whether they are 503A or 503B designated, or provide information on batch testing or quality assurance practices.

Patients considering compounded GLP-1 medications through any referral service — including Canada Med Stop — should ask directly:

• Which licensed compounding pharmacy fills the prescription
• Whether a Certificate of Analysis (CoA) is available
• Whether the pharmacy holds PCAB or NABP accreditation
• How the prescribing provider documents patient-specific medical need under current post-shortage regulations

These questions matter because the regulatory landscape for compounded GLP-1 access has narrowed since the FDA resolved the semaglutide shortage in 2025, and current permissibility depends on patient-specific clinical need and evolving enforcement priorities.

Note: Canada Med Stop’s compounded semaglutide availability is unconfirmed at time of publication — patients should contact the service directly to verify before ordering. No pricing data or third-party reviews are available for this provider at this time. No medical director is publicly listed. Canada Med Stop functions as a pharmacy referral service rather than a full-service telehealth weight loss clinic — patients require a valid prescription from a licensed provider before ordering. Importing prescription drugs from Canada operates in a regulatory grey area under U.S. federal law. All information should be verified directly at canadamedstop.com before proceeding.